| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.0105-2896.2006.00417.X |
| P698 | PubMed publication ID | 16903916 |
| P50 | author | David A. Hafler | Q25004567 |
| P2093 | author name string | Clare Baecher-Allan | |
| P2860 | cites work | Decreased FOXP3 levels in multiple sclerosis patients | Q40414528 |
| Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. | Q40801370 | ||
| Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 | ||
| Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
| Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood | Q41973912 | ||
| Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood | Q41988688 | ||
| Suppressor T cells in human diseases | Q42971257 | ||
| The coexpression of CD45RA and CD45RO isoforms on T cells during the S/G2/M stages of cell cycle. | Q43487369 | ||
| Autoreactive T cells in healthy individuals | Q44885053 | ||
| Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity | Q46681223 | ||
| CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. | Q47643874 | ||
| Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. | Q52011695 | ||
| Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. | Q52012409 | ||
| Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. | Q53654834 | ||
| The role of CD4+ CD25+ immunoregulatory T cells in the induction of autoimmune gastritis | Q57240587 | ||
| Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis | Q57350588 | ||
| A human suppressor T cell clone which recognizes an autologous helper T cell clone | Q59087740 | ||
| Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes | Q24673317 | ||
| A haplotype map of the human genome | Q24679827 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro | Q33942128 | ||
| Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation | Q33993967 | ||
| A history of prostate cancer treatment | Q34013878 | ||
| Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis | Q34311395 | ||
| On the ontogeny and physiology of regulatory T cells | Q34448405 | ||
| Suppressor T cells--they're back and critical for regulation of autoimmunity! | Q34448465 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. | Q34518941 | ||
| Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
| Inhibition of human CD4(+)CD25(+high) regulatory T cell function | Q34529239 | ||
| Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals | Q34852739 | ||
| The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells | Q35026181 | ||
| The peripheral generation of CD4+ CD25+ regulatory T cells | Q35154721 | ||
| Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis | Q35740840 | ||
| Applying a new generation of genetic maps to understand human inflammatory disease | Q35998808 | ||
| Early signaling defects in human T cells anergized by T cell presentation of autoantigen | Q36231544 | ||
| Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens | Q36342014 | ||
| Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells | Q36342722 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade | Q36369151 | ||
| Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II | Q36399471 | ||
| CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status | Q36399748 | ||
| Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia | Q36403785 | ||
| Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis | Q37356882 | ||
| P921 | main subject | autoimmune disease | Q8084905 |
| P304 | page(s) | 203-216 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Human regulatory T cells and their role in autoimmune disease | |
| P478 | volume | 212 |
| Q33306704 | A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases |
| Q37707149 | A quantitative increase in regulatory T cells controls development of vitiligo. |
| Q34634834 | A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. |
| Q24293709 | Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells |
| Q35748567 | Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment |
| Q37164758 | Advances in type I diabetes associated tolerance mechanisms |
| Q53063140 | An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes. |
| Q24627149 | Application of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetes |
| Q53112790 | Assessment of a novel flow cytometry technique of one-step intracellular staining: example of FOXP3 in clinical samples. |
| Q38645090 | Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge. |
| Q33811894 | Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy |
| Q81176004 | Autoimmunity in common variable immunodeficiency |
| Q33584997 | Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival |
| Q39631326 | Basal cell carcinoma arising from xeroderma pigmentosum: a case report and an immunohistochemical study |
| Q37329670 | Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. |
| Q51756122 | CCR9 AND CCR7 are overexpressed in CD4- CD8- thymocytes of myasthenia gravis patients. |
| Q37274074 | CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. |
| Q37366174 | CD25+ T cells induce Helicobacter pylori-specific CD25- T-cell anergy but are not required to maintain persistent hyporesponsiveness |
| Q43749801 | CD4+ CD25(high) Foxp3+ regulatory T cells downregulate human Vdelta2+ T-lymphocyte function triggered by anti-CD3 or phosphoantigen |
| Q37905796 | CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases |
| Q44173014 | Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis |
| Q51889320 | Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy. |
| Q45873782 | Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome. |
| Q36955880 | Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia |
| Q41876934 | Combining Treg therapy with mixed chimerism: Getting the best of both worlds |
| Q81356139 | Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level |
| Q41856507 | Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion |
| Q46341919 | Empirical modeling of T cell activation predicts interplay of host cytokines and bacterial indole. |
| Q88953756 | Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells |
| Q27006548 | Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms |
| Q42639405 | Ex vivo expansion of human Tregs by rabbit ATG is dependent on intact STAT3-signaling in CD4⁺ T cells and requires the presence of monocytes |
| Q29307487 | FOXP3+ regulatory T cells in the human immune system |
| Q24623384 | Foxp3 occupancy and regulation of key target genes during T-cell stimulation |
| Q36493019 | Functional defect in regulatory T cells in myasthenia gravis |
| Q33748026 | Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells |
| Q40055892 | Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3. |
| Q51738569 | Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. |
| Q37682606 | Heme oxygenase-1: its therapeutic roles in inflammatory diseases |
| Q61711484 | Human CD4low CD25high regulatory T cells indiscriminately kill autologous activated T cells |
| Q24656069 | Human T regulatory cell therapy: take a billion or so and call me in the morning |
| Q37131908 | Human regulatory T cells and autoimmunity |
| Q34636235 | Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells. |
| Q36230202 | Human seminal plasma fosters CD4(+) regulatory T-cell phenotype and transforming growth factor-β1 expression |
| Q35156282 | IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function |
| Q34722857 | Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme |
| Q42692619 | Immunological and histochemical analyses of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders |
| Q36626285 | Immunopathogenesis of IBD: insufficient suppressor function in the gut? |
| Q36832873 | Immunopathogenesis of multiple sclerosis |
| Q36409570 | Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis |
| Q36991276 | Impairment of regulatory T-cell function in autoimmune thyroid disease. |
| Q34599210 | Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients |
| Q36059631 | Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype |
| Q40381618 | Induction of inducible CD4+CD25+Foxp3+ regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV). |
| Q34006674 | Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice |
| Q37445891 | Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice |
| Q41824648 | Inhibitory oligodeoxynucleotides downregulate herpes simplex virus-induced plasmacytoid dendritic cell type I interferon production and modulate cell function |
| Q51075813 | Intracellular Flow Cytometry Improvements in Clinical Studies. |
| Q37836540 | Loss of tolerance to self after transplant |
| Q37209541 | Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis |
| Q38352941 | Molecular characterisation of porcine Forkhead-box p3 (Foxp3). |
| Q42733420 | Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis |
| Q37258383 | Multiple sclerosis and regulatory T cells |
| Q81342162 | Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis |
| Q33869793 | Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression |
| Q37273292 | Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus |
| Q61711474 | Older age of rheumatoid arthritis onset is associated with higher activation status of peripheral blood CD4(+) T cells and disease activity |
| Q39017833 | Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial |
| Q37312476 | Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo |
| Q48162560 | PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin. |
| Q41140315 | PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells |
| Q50472684 | Partial dysfunction of Treg activation in sickle cell disease. |
| Q42418046 | Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis |
| Q34700397 | Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion. |
| Q64953964 | Radon Therapy for Autoimmune Diseases Pemphigus and Diabetes: 2 Case Reports. |
| Q64907588 | Recovery From Rheumatoid Arthritis Following 15 Months of Therapy With Low Doses of Ionizing Radiation: A Case Report. |
| Q37187413 | Reduced skin homing by functional Treg in vitiligo |
| Q34475294 | Regulatory T cell kinetics in the peripheral blood of patients with Crohn's disease |
| Q37636470 | Regulatory T cells and tolerance induction |
| Q38191610 | Regulatory T cells as immunotherapy |
| Q82644053 | Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients |
| Q38068406 | Regulatory T cells in HIV infection: can immunotherapy regulate the regulator? |
| Q26825063 | Regulatory T cells in autoimmune neuroinflammation |
| Q36863866 | Regulatory T cells in health and disease |
| Q38020963 | Regulatory T cells in the central nervous system |
| Q41852894 | Regulatory T cells in type 1 autoimmune pancreatitis |
| Q36891917 | Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. |
| Q36212618 | Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases |
| Q35044185 | Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts |
| Q51342014 | Roles of Regulatory T and B Cells in IgG4-Related Disease. |
| Q42066000 | Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets |
| Q43295185 | Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression? |
| Q28081582 | T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview |
| Q37324840 | T cells in rheumatoid arthritis |
| Q36832869 | The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology? |
| Q93167080 | The Role of MicroRNAs in Regulatory T Cells |
| Q40113685 | The Role of the Ikaros Family of Transcription Factors in Regulatory T cell Development and Function |
| Q34922215 | The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation |
| Q40508720 | The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. Johnson |
| Q42112037 | The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo |
| Q37528094 | The plasticity of human Treg and Th17 cells and its role in autoimmunity |
| Q38650455 | The potential role of cell surface complement regulators and circulating CD4+ CD25+ T-cells in the development of autoimmune myasthenia gravis |
| Q36747499 | The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease |
| Q36407758 | The role of natural killer cells in curbing neuroinflammation |
| Q37199648 | The role of regulatory T cells in multiple sclerosis |
| Q42739551 | Thymic self-antigen expression for the design of a negative/tolerogenic self-vaccine against type 1 diabetes |
| Q36959215 | Thymic versus induced regulatory T cells - who regulates the regulators? |
| Q37157936 | Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-gamma, interleukin-17, and antibody responses |
| Q37632479 | Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. |
| Q37136949 | Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells |
| Q89675907 | Tuning T helper cell differentiation by ITK |
| Q29617184 | Type 2 diabetes as an inflammatory disease |
| Q41897453 | WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells |
Search more.